Search

The summer programs connect high school and medical school students with MSK faculty while offering the opportunity for student-to-student mentorship.

The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012.

A number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I studies are already demonstrating dramatic results.

Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.

Physicians at Memorial Sloan Kettering Cancer Center (MSK) have developed and validated clinical calculators to help patients estimate their likelihood of avoiding a recurrence after treatment for colorectal cancer.

Memorial Sloan Kettering Cancer Center (MSK) experts shared the results from cutting-edge advances in cancer research at the European Society of Medical Oncology (ESMO) Congress 2024, held in Barcelona, Spain, September 13 to 17, 2024.

A large cohort of patients with high-risk bladder cancer who underwent radical cystectomy and urinary tract reconstruction at Memorial Sloan Kettering Cancer Center reported favorable recovery and health-related quality of life within 24 months across most outcome measures.